Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06036927 |
| Consolidated Lead Sponsor | Chia Tai Tianqing Pharmaceutical Group Co |
| Therapeutic Condition Cohort | Respiratory and Pulmonary |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | COMPLETED |
| Registered Enrollment | 80 participants (ACTUAL) |
| Registered Start Date | 2023-12-08 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| ZhuJiang Hospital of Southern Medical University | Guangzhou, China | Open Hospital Dossier -> |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.